ABL1 and leukemia: Similarly, deleting the remaining normal copy of ABL1 in BCR-ABL1+ murine leukemia stem cells led to more aggressive disease, enhanced proliferation, inhibition of genotoxic stress-induced apoptosis and increased chromosomal aberrations [12].